US Map / North Carolina
State NC

Clinical Trials in North Carolina

Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.

Total Trials
352
Recruiting Now
352
← Back to US Map
Top Conditions in North Carolina
Breast Cancer (9)Obesity (6)Multiple Myeloma (6)Endometrial Cancer (5)Alzheimer Disease (5)Prostate Cancer (4)Advanced Solid Tumor (4)Non-Small Cell Lung Cancer (4)Metastatic Breast Cancer (3)Heart Failure With Preserved Ejection Fraction (3)Lung Cancer (3)Ulcerative Colitis (3)
NCT02708134 N/A
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Condition
Cardiac Arrest
Enrollment
7,000 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT04262206 Phase 4
Recruiting
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Condition
Cognitive Impairment, Mild
Enrollment
20,000 pts
Location
United States, Puerto Rico
Sponsor
Duke University
View Trial →
NCT06581406 Phase 2, Phase 3
Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in C...
Condition
Metastatic Uveal Melanoma
Enrollment
280 pts
Location
United States, United Kingdom
Sponsor
Replimune Inc.
View Trial →
NCT05498038 N/A
Recruiting
Exercise Reset for Concussion in a Military Environment
Condition
Brain Concussion
Enrollment
168 pts
Location
United States
Sponsor
State University of New York a
View Trial →
NCT01790152 N/A
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopath...
Condition
Hodgkin Lymphoma in Remission
Enrollment
420 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06635148 Phase 2
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Part...
Condition
Geographic Atrophy
Enrollment
274 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT07025785 N/A
Recruiting
Molecular Residual Disease Assessment in a Representative Diverse Population of ...
Condition
Breast Cancer
Enrollment
100 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
View Trial →
NCT05066217 Phase 3
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Sy...
Condition
Lennox Gastaut Syndrome
Enrollment
260 pts
Location
United States
Sponsor
Epygenix
View Trial →
NCT06511778 Phase 4
Recruiting
sTErnAl heMostasiS Trial
Condition
Excessive Bleeding During Surgery
Enrollment
60 pts
Location
United States
Sponsor
WakeMed Health and Hospitals
View Trial →
NCT05525663 N/A
Recruiting
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserv...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
880 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT04100564 N/A
Recruiting
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
Condition
Trauma Injury
Enrollment
2,009 pts
Location
United States
Sponsor
Jason Sperry
View Trial →
NCT07181109 Phase 3
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Eit...
Condition
High Risk Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT07360314 Phase 1
Recruiting
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
138 pts
Location
United States, Canada, Japan
Sponsor
EMD Serono Research & Developm
View Trial →
NCT05061004 N/A
Recruiting
Cephea Early Feasibility Study
Condition
Mitral Regurgitation
Enrollment
50 pts
Location
United States, Canada
Sponsor
Abbott Medical Devices
View Trial →
NCT02254863 Phase 1
Recruiting
UCB Transplant of Inherited Metabolic Diseases With Administration of Intratheca...
Condition
Adrenoleukodystrophy
Enrollment
40 pts
Location
United States
Sponsor
Joanne Kurtzberg, MD
View Trial →
NCT07225114 Phase 2
Recruiting
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) I...
Condition
Breast Cancer
Enrollment
40 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
View Trial →
NCT04565028 N/A
Recruiting
Functional Outcomes of Cannabis Use (FOCUS) in Veterans With Posttraumatic Stres...
Condition
PTSD
Enrollment
40 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT04862663 Phase 3
Recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Ca...
Condition
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Enrollment
895 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05839730 N/A
Recruiting
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
105 pts
Location
United States
Sponsor
Medtronic Cardiac Rhythm and H
View Trial →
NCT06587230 N/A
Recruiting
Teachers Leading the Front Lines - North Carolina (Tealeaf-NC)
Condition
Child Behavior
Enrollment
312 pts
Location
United States
Sponsor
University of North Carolina,
View Trial →
NCT07070232 Phase 1, Phase 2
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe a...
Condition
Advanced Solid Tumor
Enrollment
980 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT06866964 Phase 2
Recruiting
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboemboli...
Condition
Germ Cell Tumor
Enrollment
35 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT04674969 N/A
Recruiting
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vascula...
Condition
Peripheral Vascular Diseases
Enrollment
5,000 pts
Location
United States, Australia, Austria
Sponsor
Boston Scientific Corporation
View Trial →
NCT04561518 N/A
Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-M...
Condition
Transthyretin-Mediated Amyloidosis
Enrollment
1,500 pts
Location
United States, Brazil, Bulgaria
Sponsor
Alnylam Pharmaceuticals
View Trial →
Page 7 of 15 — 352 trials total
← Prev Next →